Article
A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigators.
Journal of acquired immune deficiency syndromes (1999) - 15 Apr 2005
Dunn D T, Green H, Loveday C, Rinehart A, Pillay D, Fisher M, McCormack S, Babiker A G, Darbyshire J H
Abstract excerpt
OBJECTIVES: To assess the clinical utility of phenotypic resistance testing in addition to genotypic resistance testing among HIV-1-infected patients experiencing virologic failure and with limited therapeutic options. DESIGN: Multicenter randomized trial. METHODS: Patients were eligible if a decision had been made to switch antiretroviral therapy, the most recent HIV-1 RNA plasma viral load (VL) exceeded 2000...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.